The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
805
November 17, 1989
View Complete Issue         Table of Contents 2019 
Is Indapamide (Lozol) Safer Than A Thiazide?
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Is Indapamide (Lozol) Safer Than A Thiazide?
November 17, 1989 (Issue: 805)
Recent advertisements for indapamide (Lozol - Rorer), an oral antihypertensive/diuretic (Medical Letter, 26:17, 1984), claim that the drug, unlike thiazide diuretics, does not significantly increase serum cholesterol and has a minimal impact on...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Is Indapamide (Lozol) Safer Than A Thiazide?
Article code: 805b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.